13 11月 2018 by admin in UncategorizedComments Tempest Data Provide POC for PPAR Alpha’s Role in Cancer
06 11月 2018 by admin in UncategorizedComments resTORbio Appoints Michael Grissinger to its Board of Directors
06 11月 2018 by admin in UncategorizedComments Crescendo Biologics wins “Biotech Company of the Year” at the Cambridge Independent Science and Technology Awards 2018
05 11月 2018 by admin in UncategorizedComments Crescendo Biologics announces early licensing by Takeda of first oncology-targeted Humabody®
16 10月 2018 by admin in UncategorizedComments Centrexion Therapeutics Announces Two CNTX-4975 Presentations at the 2018 American College of Rheumatology Annual Meeting
08 10月 2018 by admin in UncategorizedComments Crescendo Biologics appoints SVP CMC, Dr Richard Williams, and new CDMO partner, as it advances towards the clinic
02 10月 2018 by admin in UncategorizedComments Crescendo Biologics shortlisted for Private Financing Deal of the Year at 2018 Scrip Awards
24 9月 2018 by admin in UncategorizedComments Centrexion Therapeutics Appoints Andrew Partridge as Executive Vice President, Chief Commercial Officer
